Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Research Article May 24 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
Cancer Immunol Res (2022)
Research Article May 23 2022
Comprehensive characterizations of immune receptor repertoire in tumors and cancer immunotherapy studies
Cancer Immunol Res canimm.0965.2021.
Research Article May 20 2022
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multi-Omics Analysis
Cancer Immunol Res canimm.1101.2022-1-3 09:35:19.220.
Research Article May 19 2022
P2RX7 enhances tumor control by CD8+ T cells in adoptive cell therapy.
Cancer Immunol Res canimm.0691.2021.
Research Article May 19 2022
Systemic immune dysfunction in cancer patients driven by IL6 induction of LAG3 in peripheral CD8+ T cells
Cancer Immunol Res canimm.0736.2020.
Research Article May 18 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
Cancer Immunol Res (2022)
Research Article May 17 2022
High mobility group protein B1 decreases surface localization of PD-1 to augment T-cell activation
Cancer Immunol Res canimm.0652.2021.
Research Article May 17 2022
Modified manufacturing process modulates CD19CAR T-cell engraftment fitness and leukemia-free survival in pediatric and young adult subjects
Cancer Immunol Res canimm.CIR-21-0501-E.2021.
Research Article May 13 2022
Epigenetic repression of STING by MYC promotes immune evasion and resistance to immune checkpoint inhibitors in triple negative breast cancer
Cancer Immunol Res canimm.0826.2021.
Research Article May 11 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
Cancer Immunol Res (2022)
Research Article May 11 2022
Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
Cancer Immunol Res (2022)
Article Commentary May 11 2022
Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study Immunotherapy
Cancer Immunol Res (2022)
Research Article May 10 2022
T Cell–Mediated Targeted Delivery of Anti–PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site
Cancer Immunol Res (2022)
Research Article May 10 2022
Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Cancer Immunol Res (2022)
Research Article May 4 2022
Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy
Cancer Immunol Res (2022)
Research Article May 3 2022
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
Cancer Immunol Res (2022)
Review Article April 26 2022
Coming of Age: Human Genomics and the Cancer–Immune Set Point
Cancer Immunol Res (2022)
Close Modal

or Create an Account

Close Modal
Close Modal